As of 2026-04-05, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (327.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.29 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -7728.0%.
The range of the Relative Valuation is (281.96) - (365.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 21.2x | 19.2x |
| Forward P/E multiples | 14.9x - 21.0x | 18.5x |
| Fair Price | (281.96) - (365.40) | (327.24) |
| Upside | -6672.4% - -8617.4% | -7728.0% |
| Date | P/E |
| 2026-04-02 | -0.25 |
| 2026-04-01 | -0.26 |
| 2026-03-31 | -0.23 |
| 2026-03-30 | -0.24 |
| 2026-03-27 | -0.25 |
| 2026-03-26 | -0.26 |
| 2026-03-25 | -0.26 |
| 2026-03-24 | -0.25 |
| 2026-03-23 | -0.25 |
| 2026-03-20 | -0.27 |
| 2026-03-19 | -0.26 |
| 2026-03-18 | -0.27 |
| 2026-03-17 | -0.26 |
| 2026-03-16 | -0.26 |
| 2026-03-13 | -0.22 |
| 2026-03-12 | -0.23 |
| 2026-03-11 | -0.24 |
| 2026-03-10 | -0.25 |
| 2026-03-09 | -0.24 |
| 2026-03-06 | -0.25 |
| 2026-03-05 | -0.25 |
| 2026-03-04 | -0.26 |
| 2026-03-03 | -0.25 |
| 2026-03-02 | -0.26 |
| 2026-02-27 | -0.26 |
| 2026-02-26 | -0.27 |
| 2026-02-25 | -0.28 |
| 2026-02-24 | -0.29 |
| 2026-02-23 | -0.28 |
| 2026-02-20 | -0.29 |
| 2026-02-19 | -0.30 |
| 2026-02-18 | -0.27 |
| 2026-02-17 | -0.29 |
| 2026-02-13 | -0.28 |
| 2026-02-12 | -0.28 |
| 2026-02-11 | -0.29 |
| 2026-02-10 | -0.29 |
| 2026-02-09 | -0.30 |
| 2026-02-06 | -0.33 |
| 2026-02-05 | -0.31 |
| 2026-02-04 | -0.32 |
| 2026-02-03 | -0.34 |
| 2026-02-02 | -0.34 |
| 2026-01-30 | -0.34 |
| 2026-01-29 | -0.36 |
| 2026-01-28 | -0.39 |
| 2026-01-27 | -0.41 |
| 2026-01-26 | -0.38 |
| 2026-01-23 | -0.38 |
| 2026-01-22 | -0.36 |